The mitochondrial permeability transition pore and its role in anaesthesia-triggered cellular protection during ischaemia-reperfusion injury

Anaesthesia and Intensive Care

Volumn 40, Issue 1, 2012, Pages 46-70

  Andrews, D T ^a,b   Royse, C F ^a,b   Royse, A G ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Anaesthesia; Anaesthetic agents; Apoptosis; Cell death; Cellular protection; Ischaemia reperfusion injury; Mitochondrial permeability transition pore

Indexed keywords

ADENOSINE TRIPHOSPHATE; DESFLURANE; ENFLURANE; ETOMIDATE; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; MIDAZOLAM; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROPOFOL; SEVOFLURANE; SUFENTANIL; THIOPENTAL;

ANESTHESIA; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; DRUG PROTEIN BINDING; ELECTRON TRANSPORT; HEART PROTECTION; ISCHEMIA; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; NEUROPROTECTION; REPERFUSION INJURY; REVIEW;

EID: 84856448692     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1204000106     Document Type: Review

References (218)

1. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009; 16:3-11.
2. Diaz LF, Chiong M, Quest AFG, Lavandero S, Stutzin A. Mechanisms of cell death: molecular insights and therapeutic perspectives. Cell Death Differ 2005; 12:1449-1456. (Pubitemid 41521937)
3. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005; 4:139-163. (Pubitemid 41351311)
4. Giusti C, Luciani M-F, Klein G, Aubry L, Tresse E, Kosta A et al. Necrotic cell death: From reversible mitochondrial uncoupling to irreversible lysosomal permeabilization. Exp Cell Res 2009; 315:26-38.
5. Ruiz-Meana M, Abellan A, Miro-Casas E, Garcia-Dorado D. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes. Basic Res Cardiol 2007; 102:542-552. (Pubitemid 47578399)
6. Crompton M, Costi A. A heart mitochondrial Ca2(+)- dependent pore of possible relevance to re-perfusion-induced injury. Evidence that ADP facilitates pore interconversion between the closed and open states. Biochem J 1990; 266:33-39. (Pubitemid 20069017)
7. Rasola A, Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 2007; 12:815-833. (Pubitemid 46653292)
8. Crompton M, Costi A. Kinetic evidence for a heart mitochondrial pore activated by Ca2+, inorganic phosphate and oxidative stress. A potential mechanism for mitochondrial dysfunction during cellular Ca2+ overload. Eur J Biochem 1988; 178:489-501. (Pubitemid 19021853)
9. Baranov SV, Stavrovskaya IG, Brown AM, Tyryshkin AM, Kristal BS. Kinetic model for Ca2+-induced permeability transition in energized liver mitochondria discriminates between inhibitor mechanisms. J Biol Chem 2008; 283:665-676.
10. Kim J-S, Jin Y, Lemasters JJ. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2006; 290:H2024-H2034.
11. Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem 1992; 267:8834-8839.
12. Connern CP, Halestrap AP. Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem J 1994; 302 (Pt 2):321-324. (Pubitemid 24280079)
13. Halestrap AP. Calcium-dependent opening of a non-specific pore in the mitochondrial inner membrane is inhibited at pH values below 7. Implications for the protective effect of low pH against chemical and hypoxic cell damage. Biochem J 1991; 278 (Pt 3):715-719.
14. Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995; 307 (Pt 1):93-98.
15. Bernardi P, Vassanelli S, Veronese P, Colonna R, Szabo I, Zoratti M. Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J Biol Chem 1992; 267:2934-2939.
16. Halestrap AP, Connern CP, Griffiths EJ, Kerr PM. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem 1997; 174:167-172. (Pubitemid 27404185)
17. Waldmeier PC, Feldtrauer J-J, Qian T, Lemasters JJ. Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol Pharmacol 2002; 62:22-29. (Pubitemid 34680512)
18. Clarke SJ, McStay GP, Halestrap AP. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin- D at a different site from cyclosporin A. J Biol Chem 2002; 277:34793-34799.
19. Halestrap AP, Davidson AM. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 1990; 268:153-160. (Pubitemid 20166664)
20. Imberti R, Nieminen AL, Herman B, Lemasters JJ. Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine. J Pharmacol Exp Ther 1993; 265:392-400. (Pubitemid 23320987)
21. Walter L, Nogueira V, Leverve X, Heitz MP, Bernardi P, Fontaine E. Three classes of ubiquinone analogs regulate the mitochondrial permeability transition pore through a common site. J Biol Chem 2000; 275:29521-29527. (Pubitemid 32043828)
22. Pravdic D, Sedlic F, Mio Y, Vladic N, Bienengraeber M, Bosnjak ZJ. Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway. Anesthesiology 2009; 111:267-274.
23. Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelini GD, Halestrap AP. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 2000; 45:360-369. (Pubitemid 30069501)
24. Qian T, Herman B, Lemasters JJ. The mitochondrial permeability transition mediates both necrotic and apoptotic death of hepatocytes exposed to Br-A23187. Toxicol Appl Pharmacol 1999; 154:117-125. (Pubitemid 29072493)
25. Abramov AY, Duchen MR. Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity. Biochim Biophys Acta 2008; 1777:953-964.
26. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; 9:231-241. (Pubitemid 351301823)
27. Huerta S, Goulet EJ, Huerta-Yepez S, Livingston EH. Screening and detection of apoptosis. J Surg Res 2007; 139:143-156. (Pubitemid 46482558)
28. Brady NR, Hamacher-Brady A, Gottlieb RA. Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim Biophys Acta 2006; 1757:667-678.
29. Culmsee C, Zhu C, Landshamer S, Becattini B, Wagner E, Pellecchia M et al. Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci 2005; 25:10262-10272. (Pubitemid 41636223)
30. Kirkland RA, Windelborn JA, Kasprzak JM, Franklin JL. A Bax-induced pro-oxidant state is critical for cytochrome c release during programmed neuronal death. J Neurosci 2002; 22:6480-6490. (Pubitemid 35386404)
31. Liu H-R, Gao E, Hu A, Tao L, Qu Y, Most P. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion. Circulation 2005; 111:90-96. (Pubitemid 40070849)
32. Plesnila N, Zinkel S, Amin-Hanjani S, Qiu J, Korsmeyer SJ, Moskowitz MA. Function of BID - a molecule of the bcl-2 family - in ischemic cell death in the brain. Eur Surg Res 2002; 34:37-41. (Pubitemid 34195694)
33. Gupta S, Kass GEN, Szegezdi E, Joseph B. The mitochondrial death pathway: a promising therapeutic target in diseases. J Cell Mol Med 2009; 13:1004-1033.
34. Oberst A, Bender C, Green DR. Living with death: the evolution of the mitochondrial pathway of apoptosis in animals. Cell Death Differ 2008; 15:1139-1146. (Pubitemid 351850966)
35. Riedl SJ, Salvesen GS. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007; 8:405-413. (Pubitemid 46643237)
36. Hirakawa A, Takeyama N, Nakatani T, Tanaka T. Mitochondrial permeability transition and cytochrome c release in ischemia-reperfusion injury of the rat liver. J Surg Res 2003; 111:240-247. (Pubitemid 36808916)
37. Ryu S, Lin S-C, Ugel N, Antoniotti M, Mishra B. Mathematical modeling of the formation of apoptosome in intrinsic pathway of apoptosis. Syst Synth Biol 2008; 2:49-66.
38. Cande C, Cecconi F, Dessen P, Kroemer G. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci 2002; 115:4727-4734. (Pubitemid 36054627)
39. Petit PX, Goubern M, Diolez P, Susin SA, Zamzami N, Kroemer G. Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: the impact of irreversible permeability transition. FEBS Lett 1998; 426:111-116. (Pubitemid 28198166)
40. Scarlett JL, Sheard PW, Hughes G, Ledgerwood EC, Ku HH, Murphy MP. Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett 2000; 475:267-272. (Pubitemid 30408466)
41. Hamacher-Brady A, Brady NR, Gottlieb RA. The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy. Cardiovasc Drugs Ther 2006; 20:445-462. (Pubitemid 46150867)
42. Zong W-X, Thompson CB. Necrotic death as a cell fate. Genes Dev 2006; 20:1-15. (Pubitemid 43042662)
43. Lockshin RA, Zakeri Z. Apoptosis, autophagy, and more. Int J Biochem Cell Biol 2004; 36:2405-2419. (Pubitemid 39119755)
44. Broughton BRS, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke 2009; 40:e331-e339.
45. Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circ Res 2009; 104:150-158.
46. Nicotera P, Leist M, Ferrando-May E. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 1998; 102-103:139-142. (Pubitemid 29021213)
47. Monceau V, Belikova Y, Kratassiouk G, Robidel E, Russo- Marie F, Charlemagne D. Myocyte apoptosis during acute myocardial infarction in rats is related to early sarcolemmal translocation of annexin A5 in border zone. Am J Physiol Heart Circ Physiol 2006; 291:H965-H971. (Pubitemid 44175107)
48. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996; 28:2005-2016. (Pubitemid 26340560)
49. Johnston JM, Khalid S, Sansom MSP. Conformational dynamics of the mitochondrial ADP/ATP carrier: a simulation study. Mol Membr Biol 2008; 25:506-517.
50. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res 2004; 61:372-385. (Pubitemid 38210145)
51. Duchen MR, McGuinness O, Brown LA, Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res 1993; 27:1790-1794. (Pubitemid 23337871)
52. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol 2008; 294:C460-C466. (Pubitemid 351276913)
53. Lesnefsky EJ, Gudz TI, Migita CT, Ikeda-Saito M, Hassan MO, Turkaly PJ et al. Ischemic injury to mitochondrial electron transport in the aging heart: damage to the ironsulfur protein subunit of electron transport complex III. Arch Biochem Biophys 2001; 385:117-128. (Pubitemid 32988989)
54. Lesnefsky EJ, Slabe TJ, Stoll MS, Minkler PE, Hoppel CL. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 2001; 280:H2770-H2778.
55. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ. Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J Pharmacol Exp Ther 2006; 319:1405-1412.
56. Bosetti F, Baracca A, Lenaz G, Solaini G. Increased state 4 mitochondrial respiration and swelling in early post-ischemic reperfusion of rat heart. FEBS Lett 2004; 563:161-164. (Pubitemid 38471592)
57. Dittrich M, Hayashi S, Schulten K. On the mechanism of ATP hydrolysis in F1-ATPase. Biophys J 2003; 85:2253-2266.
58. Jennings RB, Steenbergen C Jr. Nucleotide metabolism and cellular damage in myocardial ischemia. Annu Rev Physiol 1985; 47:727-749. (Pubitemid 15142408)
59. Wu F, Zhang EY, Zhang J, Bache RJ, Beard DA. Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic hearts. J Physiol 2008; 586:4193-4208.
60. Maddaiah VT, Kumbar U. Membrane permeability transition promoted by phosphate enhances 1-anilino-8-naphthalene sulfonate fluorescence in calcium-loaded liver mitochondria. J Bioenerg Biomembr 1993; 25:419-427. (Pubitemid 23260262)
61. Nicholls DG. The regulation of extramitochondrial free calcium ion concentration by rat liver mitochondria. Biochem J 1978; 176:463-474.
62. Nicholls DG, Crompton M. Mitochondrial calcium transport. FEBS Lett 1980; 111:261-268. (Pubitemid 10121780)
63. Inoue T, Yoshida Y, Nishimura M, Kurosawa K, Tagawa K. Ca(2+)-induced, phospholipase-independent injury during reoxygenation of anoxic mitochondria. Biochim Biophys Acta 1993; 1140:313-320. (Pubitemid 23015697)
64. Nishida T, Inoue T, Kamiike W, Kawashima Y, Tagawa K. Involvement of Ca2+ release and activation of phospholipase A2 in mitochondrial dysfunction during anoxia. J Biochem 1989; 106:533-538. (Pubitemid 19232818)
65. Jambrina E, Alonso R, Alcalde M, del Carmen RM, Serrano A, Martinez-A C et al. Calcium influx through receptor-operated channel induces mitochondria-triggered paraptotic cell death. J Biol Chem 2003; 278:14134-14145. (Pubitemid 36799960)
66. Griffiths EJ, Ocampo CJ, Savage JS, Stern MD, Silverman HS. Protective effects of low and high doses of cyclosporin A against reoxygenation injury in isolated rat cardiomyocytes are associated with differential effects on mitochondrial calcium levels. Cell Calcium 2000; 27:87-95. (Pubitemid 30150797)
67. Byrne AM, Lemasters JJ, Nieminen AL. Contribution of increased mitochondrial free Ca2+ to the mitochondrial permeability transition induced by tert-butylhydroperoxide in rat hepatocytes. Hepatology 1999; 29:1523-1531. (Pubitemid 29211056)
68. Theruvath TP, Zhong Z, Pediaditakis P, Ramshesh VK, Currin RT, Tikunov A et al. Minocycline and N-methyl-4- isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition. Hepatology 2008; 47:236-246.
69. Trost LC, Lemasters JJ. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome. Toxicol Appl Pharmacol 1997; 147:431-441. (Pubitemid 28062760)
70. Kim J-S, Qian T, Lemasters JJ. Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes. Gastroenterology 2003; 124:494-503. (Pubitemid 36169265)
71. Al-Nasser I, Crompton M. The reversible Ca2+-induced permeabilization of rat liver mitochondria. Biochem J 1986; 239:19-29. (Pubitemid 17178369)
72. Brustovetsky N, Klingenberg M. Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. Biochemistry 1996; 35:8483-8488. (Pubitemid 26240181)
73. Halestrap AP, Woodfield KY, Connern CP. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 1997; 272:3346-3354.
74. Huser J, Rechenmacher CE, Blatter LA. Imaging the permeability pore transition in single mitochondria. Biophys J 1998; 74:2129-2137. (Pubitemid 28157948)
75. Ruiz-Meana M, Garcia-Dorado D, Miro-Casas E, Abellan A, Soler-Soler J. Mitochondrial Ca2+ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion. Cardiovasc Res 2006; 71:715-724. (Pubitemid 44848013)
76. Wang W, Fang H, Groom L, Cheng A, Zhang W, Liu J et al. Superoxide flashes in single mitochondria. Cell 2008; 134:279-290. (Pubitemid 352010332)
77. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 2003; 278:36027-36031. (Pubitemid 37139922)
78. Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006; 58:87-114.
79. Kevin LG, Novalija E, Stowe DF. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg 2005; 101:1275-1287. (Pubitemid 41531857)
80. Brady NR, Hamacher-Brady A, Westerhoff HV, Gottlieb RA. A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. Antioxid Redox Signal 2006; 8:1651-1665. (Pubitemid 44726339)
81. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000; 192:1001-1014.
82. Giron-Calle J, Zwizinski CW, Schmid HH. Peroxidative damage to cardiac mitochondria. II. Immunological analysis of modified adenine nucleotide translocase. Arch Biochem Biophys 1994; 315:1-7. (Pubitemid 24351029)
83. Zwizinski CW, Schmid HH. Peroxidative damage to cardiac mitochondria: identification and purification of modified adenine nucleotide translocase. Arch Biochem Biophys 1992; 294:178-183.
84. Henderson PJ, Lardy HA. Bongkrekic acid. An inhibitor of the adenine nucleotide translocase of mitochondria. J Biol Chem 1970; 245:1319-1326.
85. Leung AWC, Halestrap AP. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim Biophys Acta 2008; 1777:946-952.
86. Galat A. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity - targets - functions. Curr Top Med Chem 2003; 3:1315-1347.
87. Griffiths EJ, Halestrap AP. Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin. Biochem J 1991; 274 (Pt 2):611-614.
88. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005; 434:652-658. (Pubitemid 40488558)
89. Leung AWC, Varanyuwatana P, Halestrap AP. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J Biol Chem 2008; 283:26312-26323.
90. Halestrap AP, Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta 2009; 1787:1402-1415.
91. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004; 427:461-465. (Pubitemid 38168501)
92. He L, Lemasters JJ. Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function? FEBS Lett 2002; 512:1-7. (Pubitemid 34164440)
93. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 2005; 111:194-197. (Pubitemid 40139731)
94. Baines CP, Song C-X, Zheng Y-T, Wang G-W, Zhang J, Wang O-L et al. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 2003; 92:873-880. (Pubitemid 36542528)
95. Feng J, Lucchinetti E, Ahuja P, Pasch T, Perriard J-C, Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. Anesthesiology 2005; 103:987-995. (Pubitemid 41552054)
96. Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 2003; 60:617-625. (Pubitemid 37501119)
97. He W, Zhang FJ, Wang SP, Chen G, Chen CC, Yan M. Postconditioning of sevoflurane and propofol is associated with mitochondrial permeability transition pore. J Zhejiang Univ Sci B 2008; 9:100-108. (Pubitemid 351234295)
98. Krolikowski JG, Bienengraeber M, Weihrauch D, Warltier DC, Kersten JR, Pagel PS. Inhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: the role of mitochondrial KATP channels. Anesth Analg 2005; 101:1590-1596. (Pubitemid 41720602)
99. Lemoine S, Zhu L, Beauchef G, Lepage O, Babatasi G, Ivascau C et al. Role of 70-kDa ribosomal protein S6 kinase, nitric oxide synthase, glycogen synthase kinase-3 beta, and mitochondrial permeability transition pore in desflurane-induced postconditioning in isolated human right atria. Anesthesiology 2010; 112:1355-1363.
100. Pravdic D, Mio Y, Sedlic F, Pratt PF, Warltier DC, Bosnjak ZJ et al. Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosol-independent action at reperfusion. Br J Pharmacol 2010; 160:220-232.
101. Rajesh KG, Sasaguri S, Zhitian Z, Suzuki R, Asakai R, Maeda H. Second window of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2 expression. Cardiovasc Res 2003; 59:297-307. (Pubitemid 37272024)
102. Sepac A, Sedlic F, Si-Tayeb K, Lough J, Duncan SA, Bienengraeber M et al. Isoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cells. Anesthesiology 2010; 113:906-916.
103. Wu L, Shen F, Lin L, Zhang X, Bruce IC, Xia Q. The neuroprotection conferred by activating the mitochondrial ATP-sensitive K+ channel is mediated by inhibiting the mitochondrial permeability transition pore. Neurosci Lett 2006; 402:184-189. (Pubitemid 43766457)
104. Yao Y-T, Li L-H, Chen L, Wang W-P, Li L-B, Gao C-Q. Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury: the role of radical oxygen species, extracellular signal-related kinases 1/2 and mitochondrial permeability transition pore. Mol Biol Rep 2010; 37:2439-2446.
105. Piriou V, Chiari P, Gateau-Roesch O, Argaud L, Muntean D, Salles D et al. Desflurane-induced preconditioning alters calcium-induced mitochondrial permeability transition. Anesthesiology 2004; 100:581-588. (Pubitemid 38268876)
106. Lesnefsky EJ, Chen Q, Moghaddas S, Hassan MO, Tandler B, Hoppel CL. Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem 2004; 279:47961-47967. (Pubitemid 39540947)
107. Kissin I, Aultman DF, Smith LR. Effects of volatile anesthetics on myocardial oxidation-reduction status assessed by NADH fluorometry. Anesthesiology 1983; 59:447-452. (Pubitemid 14227521)
108. Riess ML, Eells JT, Kevin LG, Camara AKS, Henry MM, Stowe DF. Attenuation of mitochondrial respiration by sevoflurane in isolated cardiac mitochondria is mediated in part by reactive oxygen species. Anesthesiology 2004; 100:498-505. (Pubitemid 38268865)
109. Riess ML, Kevin LG, McCormick J, Jiang MT, Rhodes SS, Stowe DF. Anesthetic preconditioning: the role of free radicals in sevoflurane-induced attenuation of mitochondrial electron transport in Guinea pig isolated hearts. Anesth Analg 2005; 100:46-53. (Pubitemid 40013601)
110. Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Federici A, Ruggiero FM. Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ Res 2004; 94:53-59. (Pubitemid 38064098)
111. Kevin LG, Novalija E, Riess ML, Camara AKS, Rhodes SS, Stowe DF. Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth Analg 2003; 96:949-955. (Pubitemid 36359021)
112. Novalija E, Kevin LG, Camara AKS, Bosnjak ZJ, Kampine JP, Stowe DF. Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. Anesthesiology 2003; 99:421-428. (Pubitemid 36909568)
113. Yue Y, Krenz M, Cohen MV, Downey JM, Critz SD. Menadione mimics the infarct-limiting effect of preconditioning in isolated rat hearts. Am J Physiol Heart Circ Physiol 2001; 281:H590-H595.
114. Kabir AMN, Clark JE, Tanno M, Cao X, Hothersall JS, Dashnyam S et al. Cardioprotection initiated by reactive oxygen species is dependent on activation of PKCepsilon. Am J Physiol Heart Circ Physiol 2006; 291:H1893-H1899. (Pubitemid 44497697)
115. Hassouna A, Matata BM, Galinanes M. PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium. Am J Physiol Cell Physiol 2004; 287:C1418-C1425. (Pubitemid 39382903)
116. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 2002; 55:534-543. (Pubitemid 34874948)
117. Holmuhamedov EL, Jahangir A, Oberlin A, Komarov A, Colombini M, Terzic A. Potassium channel openers are uncoupling protonophores: implication in cardioprotection. FEBS Lett 2004; 568:167-170. (Pubitemid 38757976)
118. Brennan JP, Southworth R, Medina RA, Davidson SM, Duchen MR, Shattock MJ. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovasc Res 2006; 72:313-321. (Pubitemid 44511914)
119. Yoshida K, Kawamura S, Mizukami Y, Kitakaze M. Implication of protein kinase C-alpha, delta, and epsilon isoforms in ischemic preconditioning in perfused rat hearts. J Biochem 1997; 122:506-511. (Pubitemid 27443224)
120. Uecker M, Da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M. Translocation of protein kinase C isoforms to subcellular targets in ischemic and anesthetic preconditioning. Anesthesiology 2003; 99:138-147. (Pubitemid 36799044)
121. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 2003; 98:1315-1327. (Pubitemid 36622462)
122. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Schaub MC. Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology 2002; 97:4-14. (Pubitemid 34733916)
123. Kohro S, Hogan QH, Nakae Y, Yamakage M, Bosnjak ZJ. Anesthetic effects on mitochondrial ATP-sensitive K channel. Anesthesiology 2001; 95:1435-1340.
124. Riess ML, Costa AD, Carlson R Jr, Garlid KD, Heinen A, Stowe DF. Differential increase of mitochondrial matrix volume by sevoflurane in isolated cardiac mitochondria. Anesth Analg 2008; 106:1049-1055. (Pubitemid 351450525)
125. Dos Santos P, Kowaltowski AJ, Laclau MN, Seetharaman S, Paucek P, Boudina S et al. Mechanisms by which opening the mitochondrial ATP- sensitive K(+) channel protects the ischemic heart. Am J Physiol Heart Circ Physiol 2002;283:H284-H295. (Pubitemid 34705350)
126. Korge P, Honda HM, Weiss JN. K+-dependent regulation of matrix volume improves mitochondrial function under conditions mimicking ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2005; 289:H66-H77. (Pubitemid 40934083)
127. Yao YT, Fang NX, Shi CX, Li LH. Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Chin Med J (Engl) 2010; 123:1320-1328.
128. Lecour S. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? J Mol Cell Cardiol 2009; 47:32-40.
129. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010; 87:406-423.
130. Davidson SM, Hausenloy D, Duchen MR, Yellon DM. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 2006; 38:414-419. (Pubitemid 41821888)
131. Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008; 117:2761-2768. (Pubitemid 351770456)
132. Wang J-K, Yu L-N, Zhang F-J, Yang M-J, Yu J, Yan M et al. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res 2010; 1357:142-151.
133. Lecour S. Multiple protective pathways against reperfusion injury: a SAFE path without Aktion? J Mol Cell Cardiol 2009; 46:607-609.
134. Tian Y, Zhang W, Xia D, Modi P, Liang D, Wei M. Postconditioning inhibits myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathway. J Biomed Sci 2011; 18:53.
135. Negoro S, Kunisada K, Tone E, Funamoto M, Oh H, Kishimoto T et al. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res 2000; 47:797-805.
136. Gao Q, Xia Q, Cao C-M, Zhang S-Z, Bruce IC. Role of the mitochondrial permeability transition pore in TNF-alpha-induced recovery of ventricular contraction and reduction of infarct size in isolated rat hearts subjected to ischemia/reperfusion. Conf Proc IEEE Eng Med Biol Soc 2004; 5:3622-3624. (Pubitemid 40035439)
137. Gross ER, Hsu AK, Gross GJ. The JAK/STAT pathway is essential for
138. Yao Y, Li L, Li L, Gao C, Shi C. Sevoflurane postconditioning protects chronically-infarcted rat hearts against ischemia-reperfusion injury by activation of pro-survival kinases and inhibition of mitochondrial permeability transition pore opening upon reperfusion. Biol Pharm Bull 2009; 32:1854-1861.
139. Krolikowski JG, Weihrauch D, Bienengraeber M, Kersten JR, Warltier DC, Pagel PS. Role of Erk1/2, p70s6K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo. Can J Anesth 2006; 53:174-182.
140. Ge ZD, Pravdic D, Bienengraeber M, Pratt PF Jr, Auchampach JA, Gross GJ et al. Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism. Anesthesiology 2010; 112:73-85.
141. Venkatapuram S, Wang C, Krolikowski JG, Weihrauch D, Kersten JR, Warltier DC et al. Inhibition of apoptotic protein p53 lowers the threshold of isoflurane-induced cardioprotection during early reperfusion in rabbits. Anesth Analg 2006; 103:1400-1405. (Pubitemid 44949203)
142. Pagel PS, Krolikowski JG, Neff DA, Weihrauch D, Bienengraeber M, Kersten JR et al. Inhibition of glycogen synthase kinase enhances isoflurane-induced protection against myocardial infarction during early reperfusion in vivo. Anesth Analg 2006; 102:1348-1354.
143. Yu L-N, Yu J, Zhang F-J, Yang M-J, Ding T-T, Wang J-K et al. Sevoflurane postconditioning reduces myocardial reperfusion injury in rat isolated hearts via activation of PI3K/Akt signaling and modulation of Bcl-2 family proteins. J Zhejiang Univ Sci B 2010; 11:661-672.
144. Wang C, Neff DA, Krolikowski JG, Weihrauch D, Bienengraeber M, Warltier DC et al. The influence of B-cell lymphoma 2 protein, an antiapoptotic regulator of mitochondrial permeability transition, on isoflurane-induced and ischemic postconditioning in rabbits. Anesth Analg 2006; 102:1355-1360.
145. Sztark F, Ichas F, Ouhabi R, Dabadie P, Mazat JP. Effects of the anaesthetic propofol on the calcium-induced permeability transition of rat heart mitochondria: direct pore inhibition and shift of the gating potential. FEBS Lett 1995; 368:101-104.
146. Eriksson O. Effects of the general anaesthetic Propofol on the Ca2(+)-induced permeabilization of rat liver mitochondria. FEBS Lett 1991; 279:45-48.
147. Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, Inoue M. Antioxidant protection of propofol and its recycling in erythrocyte membranes. Am J Respir Crit Care Med 2002; 165:54-60. (Pubitemid 34053357)
148. Bahri MA, Seret A, Hans P, Piette J, Deby-Dupont G, Hoebeke M. Does propofol alter membrane fluidity at clinically relevant concentrations? An ESR spin label study. Biophys Chem 2007; 129:82-91. (Pubitemid 47009013)
149. Morota S, Mansson R, Hansson MJ, Kasuya K, Shimazu M, Hasegawa E et al. Evaluation of putative inhibitors of mitochondrial permeability transition for brain disorders - specificity vs. toxicity. Exp Neurol 2009; 218:353-362.
150. Shao H, Li J, Zhou Y, Ge Z, Fan J, Shao Z et al. Dose-dependent protective effect of propofol against mitochondrial dysfunction in ischaemic/reperfused rat heart: role of cardiolipin. Br J Pharmacol 2008; 153:1641-1649. (Pubitemid 351536002)
151. Ko SH, Yu CW, Lee SK, Choe H, Chung MJ, Kwak YG et al. Propofol attenuates ischemia-reperfusion injury in the isolated rat heart. Anesth Analg 1997; 85:719-724. (Pubitemid 27418869)
152. Dawidowicz AL, Kalitynski R, Kobielski M, Pieniadz J. Influence of propofol concentration in human plasma on free fraction of the drug. Chem Biol Interact 2006; 159:149-155. (Pubitemid 43042622)
153. Mazoit JX, Samii K. Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics. Br J Clin Pharmacol 1999; 47:35-42. (Pubitemid 29043162)
154. Green TR, Bennett SR, Nelson VM. Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicol Appl Pharmacol 1994; 129:163-169. (Pubitemid 24352634)
155. De Hert SG, Cromheecke S, ten Broecke PW, Mertens E, De Blier IG, Stockman BA et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 2003; 99:314-323. (Pubitemid 36909557)
156. De Hert SG, ten Broecke PW, Mertens E, Van Sommeren EW, De Blier IG, Stockman BA et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002; 97:42-49. (Pubitemid 34733920)
157. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101:299-310. (Pubitemid 38988484)
158. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, ten Broecke PW, De Blier IG et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004; 101:9-20. (Pubitemid 38833257)
159. Xia Z, Huang Z, Ansley DM. Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane. Anesth Analg 2006; 103:527-532. (Pubitemid 44542898)
160. Zhu S-J, Han W-L, Zhu S-M, Zhou Y-F. [Protective effects of propofol preconditioning on cardiopulmonary bypass-induced apoptosis: report of 40 cases]. Zhonghua Yi Xue Za Zhi 2007; 87:2472-2475.
161. Zou H-D, Zhou Q-S, Xia W-F, Wu L-X, Cheng B-C. [Cardioprotective effects of propofol and midazolam in children with congenital heart diseases undergoing open heart surgery]. Zhonghua Yi Xue Za Zhi 2007; 87:2309-2312.
162. Bein B, Renner J, Caliebe D, Hanss R, Bauer M, Fraund S et al. The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardio-pulmonary bypass in coronary artery surgery: comparison with continuous propofol. Anaesthesia 2008; 63:1046-1055.
163. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100:II340-II344. (Pubitemid 29523557)
164. Conzen PF, Fischer S, Detter C, Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003; 99:826-833. (Pubitemid 37186071)
165. Cromheecke S, Pepermans V, Hendrickx E, Lorsomradee S, ten Broecke PW, Stockman BA et al. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg 2006; 103:289-296. (Pubitemid 44140622)
166. Cromheecke S, ten Broecke PW, Hendrickx E, Meeus R, De Hert SG. Incidence of atrial fibrillation early after cardiac surgery: can choice of the anesthetic regimen influence the incidence? Acta Anaesthesiol Belg 2005; 56:147-154. (Pubitemid 40943862)
167. Drenger B, Gilon D, Chevion M, Elami A, Meroz Y, Milgalter E et al. Myocardial metabolism altered by ischemic preconditioning and enflurane in off-pump coronary artery surgery. J Cardiothorac Vasc Anesth 2008; 22:369-376.
168. El Azab SR, Rosseel PMJ, De Lange JJ, Groeneveld ABJ, Van Strik R, Van Wijk EM et al. Effect of sevoflurane on the ex vivo secretion of TNF-alpha during and after coronary artery bypass surgery. Eur J Anaesthesiol 2003; 20:380-384. (Pubitemid 36597041)
169. El Azab SR, Rosseel PMJ, De Lange JJ, van Wijk EM, van Strik R, Scheffer GJ. Effect of VIMA with sevoflurane versus TIVA with propofol or midazolam-sufentanil on the cytokine response during CABG surgery. Eur J Anaesthesiol 2002; 19:276-282. (Pubitemid 34984202)
170. Forlani S, Tomai F, De Paulis R, Turani F, Colella DF, Nardi P et al. Preoperative shift from glibenclamide to insulin is cardioprotective in diabetic patients undergoing coronary artery bypass surgery. J Cardiovasc Surg (Torino) 2004; 45:117-122. (Pubitemid 39028867)
171. Garcia C, Julier K, Bestmann L, Zollinger A, von Segesser LK, Pasch T et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth 2005; 94:159-165. (Pubitemid 40214419)
172. Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G et al. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth 2006; 20:477-483. (Pubitemid 44119282)
173. Haroun-Bizri S, Khoury SS, Chehab IR, Kassas CM, Baraka A. Does isoflurane optimize myocardial protection during cardiopulmonary bypass? J Cardiothorac Vasc Anesth 2001; 15:418-421. (Pubitemid 32756199)
174. Huseidzinovic I, Barisin S, Bradic N, Milanovic R. Early cardioprotective effect of sevoflurane on left ventricular performance during coronary artery bypass grafting on a beating heart: randomized controlled study. Croat Med J 2007; 48:333-340. (Pubitemid 47035683)
175. Jakobsen C-J, Berg H, Hindsholm KB, Faddy N, Sloth E. The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures. J Cardiothorac Vasc Anesth 2007; 21:664-671. (Pubitemid 47464955)
176. Kanbak M, Saricaoglu F, Avci A, Ocal T, Koray Z, Aypar U. Propofol offers no advantage over isoflurane anesthesia for cerebral protection during cardiopulmonary bypass: a preliminary study of S-100beta protein levels. Can J Anesth 2004; 51:712-717. (Pubitemid 39419646)
177. Kawamura T, Kadosaki M, Nara N, Kaise A, Suzuki H, Endo E et al. Effects of sevoflurane on cytokine balance in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2006; 20:503-508. (Pubitemid 44119276)
178. Kendall JB, Russell GN, Scawn NDA, Akrofi M, Cowan CM et al. A prospective, randomised, single-blind pilot study to determine the effect of anaesthetic technique on troponin T release after off-pump coronary artery surgery. Anaesthesia 2004; 59:545-549. (Pubitemid 38744888)
179. Landoni G, Calabro MG, Marchetti C, Bignami E, Scandroglio AM, Dedola E et al. Desflurane versus propofol in patients undergoing mitral valve surgery. J Cardiothorac Vasc Anesth 2007; 21:672-627.
180. Landoni G, Zangrillo A, Fochi O, Maj G, Scandroglio AM, Morelli A et al. Cardiac protection with volatile anesthetics in stenting procedures. J Cardiothorac Vasc Anesth 2008; 22:543-547.
181. Law-Koune JD, Raynaud C, Liu N, Dubois C, Romano M, Fischler M. Sevoflurane-remifentanil versus propofol-remifentanil anesthesia at a similar bispectral level for offpump coronary artery surgery: no evidence of reduced myocardial ischemia. J Cardiothorac Vasc Anesth 2006; 20:484-492. (Pubitemid 44119263)
182. Lee M-C, Chen C-H, Kuo M-C, Kang P-L, Lo A, Liu K. Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting. Eur J Anaesthesiol 2006; 23:841-847. (Pubitemid 44464934)
183. Lucchinetti E, Hofer C, Bestmann L, Hersberger M, Feng J, Zhu M et al. Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics. Anesthesiology 2007; 106:444-457. (Pubitemid 46662209)
184. Malagon I, Hogenbirk K, van Pelt J, Hazekamp MG, Bovill JG. Effect of three different anaesthetic agents on the postoperative production of cardiac troponin T in paediatric cardiac surgery. Br J Anaesth 2005; 94:805-809. (Pubitemid 40753998)
185. Meco M, Cirri S, Gallazzi C, Magnani G, Cosseta D. Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study. Eur J Cardiothorac Surg 2007; 32:319-325. (Pubitemid 47021455)
186. Nader ND, Li CM, Khadra WZ, Reedy R, Panos AL. Anesthetic myocardial protection with sevoflurane. J Cardiothorac Vasc Anesth 2004; 18:269-274. (Pubitemid 38849411)
187. Penta de Peppo A, Polisca P, Tomai F, De Paulis R, Turani F, Zupancich E et al. Recovery of LV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 1999; 68:112-118. (Pubitemid 29338973)
188. Piriou V, Mantz J, Goldfarb G, Kitakaze M, Chiari P, Paquin S et al. Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial. Br J Anaesth 2007; 99:624-631. (Pubitemid 351773223)
189. Pouzet B, Lecharny J-B, Dehoux M, Paquin S, Kitakaze M, Mantz J et al. Is there a place for preconditioning during cardiac operations in humans? Ann Thorac Surg 2002; 73:843-848. (Pubitemid 34188325)
190. Tomai F, De Paulis R, Penta de Peppo A, Colagrande L, Caprara E, Polisca P et al. Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol 1999; 29:1007-1014. (Pubitemid 29434161)
191. Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D et al. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 2007; 24:323-331.
192. Wang X, Jarvinen O, Kuukasjarvi P, Laurikka J, Wei M, Rinne T et al. Isoflurane produces only minor preconditioning in coronary artery bypass grafting. Scand Cardiovasc J 2004; 38:287-292. (Pubitemid 39462159)
193. Yildirim V, Doganci S, Aydin A, Bolcal C, Demirkilic U, Cosar A. Cardioprotective effects of sevoflurane, isoflurane, and propofol in coronary surgery patients: a randomized controlled study. Heart Surg Forum 2009; 12:E1-E9.
194. Zadorozhnyi MV, Iavorovskii AG, Ziuliaeva TP, Isaeva AM, Vinnitskii LI, Buniatian AA. [Method of pharmacological myocardial preconditioning with halogen-containing anesthetics in cardiosurgical patients]. Anesteziol Reanimatol 2008; 5:4-8.
195. De Hert S, Vlasselaers D, Barbe R, Ory J-P, Dekegel D, Donnadonni R et al. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia 2009; 64:953-960.
196. Frassdorf J, Borowski A, Ebel D, Feindt P, Hermes M, Meemann T et al. Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery. J Thorac Cardiovasc Surg 2009; 137:1436-1442.
197. Gravel NR, Searle NR, Taillefer J, Carrier M, Roy M, Gagnon L. Comparison of the hemodynamic effects of sevoflurane anesthesia induction and maintenance vs TIVA in CABG surgery. Can J Anesth 1999; 46:240-246. (Pubitemid 29198129)
198. Parsons RS, Jones RM, Wrigley SR, MacLeod KG, Platt MW. Comparison of desflurane and fentanyl-based anaesthetic techniques for coronary artery bypass surgery. Br J Anaesth 1994; 72:430-438. (Pubitemid 24117971)
199. Helman JD, Leung JM, Bellows WH, Pineda N, Roach GW, Reeves JD 3rd et al. The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. The S.P.I. Research Group. Anesthesiology 1992; 77:47-62.
200. Guarracino F, Doroni L, Cariello C, Baldassarri R, Vullo C. [Cardiac protection is a clinical evidence]. Minerva Anestesiol 2004; 70:261-265.
201. Flier S, Post J, Concepcion AN, Kappen TH, Kalkman CJ, Buhre WF. Influence of propofol-opioid vs isoflurane-opioid anaesthesia on postoperative troponin release in patients undergoing coronary artery bypass grafting. Br J Anaesth 2010; 105:122-130.
202. Hemmerling TM, Minardi C, Zaouter C, Noiseux N, Prieto I. Sevoflurane causes less arrhythmias than desflurane after off-pump coronary artery bypass grafting: a pilot study. Ann Card Anaesth 2010; 13:116-122.
203. Huang Z, Zhong X, Irwin MG, Ji S, Wong GT, Liu Y et al. Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients. Clin Sci (Lond) 2011; 121:57-69.
204. Hoffman WE, Charbel FT, Edelman G, Ausman JI. Thiopental and desflurane treatment for brain protection. Neurosurgery 1998; 43:1050-1053. (Pubitemid 28481102)
205. Hoffman WE, Charbel FT, Edelman G, Misra M, Ausman JI. Comparison of the effect of etomidate and desflurane on brain tissue gases and pH during prolonged middle cerebral artery occlusion. Anesthesiology 1998; 88:1188-1194. (Pubitemid 28216861)
206. Kanbak M, Saricaoglu F, Akinci SB, Oc B, Balci H, Celebioglu B et al. The effects of isoflurane, sevoflurane, and desflurane anesthesia on neurocognitive outcome after cardiac surgery: a pilot study. Heart Surg Forum 2007; 10:E36-E41.
207. Royse CF, Andrews DT, Newman SN, Stygall J, Williams Z, Pang J et al. The influence of propofol or desflurane on postoperative cognitive dysfunction in patients undergoing coronary artery bypass surgery. Anaesthesia 2011; 66:455-464.
208. Schoen J, Husemann L, Tiemeyer C, Lueloh A, Sedemund- Adib B, Berger K-U et al. Cognitive function after sevoflurane- vs propofol-based anaesthesia for on-pump cardiac surgery: a randomized controlled trial. Br J Anaesth 2011; 106:840-850.
209. el Azab SR, Scheffer GJ, de Lange JJ, van Strik R, Rosseel PM. Liver and renal function after volatile induction and maintenance of anesthesia (VIMA) with sevoflurane versus TIVA with sufentanil-midazolam for CABG surgery. Acta Anaesthesiol Belg 2001; 52:281-285. (Pubitemid 33062700)
210. Lorsomradee S, Cromheecke S, Lorsomradee S, De Hert SG. Effects of sevoflurane on biomechanical markers of hepatic and renal dysfunction after coronary artery surgery. J Cardiothorac Vasc Anesth 2006; 20:684-690. (Pubitemid 44470820)
211. Story DA, Poustie S, Liu G, McNicol PL. Changes in plasma creatinine concentration after cardiac anesthesia with isoflurane, propofol, or sevoflurane: a randomized clinical trial. Anesthesiology 2001; 95:842-848.
212. Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008; 248:909-918.
213. Lucchinetti E, Ambrosio S, Aguirre J, Herrmann P, Harter L, Keel M et al. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology 2007; 106:262-268. (Pubitemid 46185170)
214. Landoni G, Biondi-Zoccai GGL, Zangrillo A, Bignami E, D'Avolio S, Marchetti C et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007; 21:502-511. (Pubitemid 47135634)
215. Seccareccia F, Perucci CA, D'Errigo P, Arca M, Fusco D, Rosato S et al. The Italian CABG Outcome Study: shortterm outcomes in patients with coronary artery bypass graft surgery. Eur J Cardiothorac Surg 2006; 29:56-62. (Pubitemid 41831349)
216. Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anesth 2006; 53:906-918. (Pubitemid 44696515)
217. Symons JA, Myles PS. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 2006; 97:127-136. (Pubitemid 44295694)
218. Yao Y-T, Li L-H. Sevoflurane versus propofol for myocardial protection in patients undergoing coronary artery bypass grafting surgery: a meta-analysis of randomized controlled trials. Chin Med Sci J 2009; 24:133-141.